Intellipharmaceutics International Inc. (IPCI)

[Samsa]

Jonas....last time the company mentioned it they said it was shelved until they partner it. I too feel they should be actively looking for a partner. It will take years to do the phases required and in 2018 Lyrica comes off patent and then they will have generics to contend with.

to be fair, it is one of my biggest complaints with the company. the inability to partner. They can get approvals but don't seem to be able to find partners. we are still waiting on Keppra and Glucho, which were already approved. we have Regabatin, which now is stalled until they partner. I think Odidi is stretched thin at times and can only do so much.

therefore, the focus has been on Rexista, which is more near term and securing the partnership for that as well getting the approval.